Freenome private stock trade

Freenome

Legal NameFreenome Inc.
HeadquartersSan Francisco, CA
SectorHealthTech

Freenome is a biotechnology company specializing in early cancer detection and precision medicine. The company focuses on developing advanced liquid biopsy tests and machine learning algorithms to identify and analyze biomarkers in blood samples. These biomarkers can provide insights into the presence of cancer and its characteristics, allowing for early diagnosis and personalized treatment recommendations.

Learn more about Freenome IPO

Secondary Pricing Information

$ .star in blue circleZX Index Value | Get ZXData access
23.31%ZX Index Value MoM Change
-7.05%ZX Index Value VS Reported Marks
pricing graph placeholder
star in blue circleTo view Pre-IPO pricing data for Freenome, log in to ZXData or contact us to request access.
<

Secondary Volume Information

$ .M star in blue circleAggregate Volume | Get ZXData access
volume graph placeholder
star in blue circleTo view Pre-IPO volume data for Freenome, log in to ZXData or contact us to request access.

Similar Companies

View More

ZXData is the leading provider of real-time secondary data on private companies. ZXData has the largest dataset of closed trades with $15bn+ in volume. In addition, it incorporates $150bn+ of buy/sell prices and $45bn+ of reported marks to provide private market investors, trading desks, lenders, and companies with unprecedented market intelligence on private companies.